Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Endometrial Neoplasms 3Stomach Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Thrombophilia 1Thrombocytopenia 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Cancer Extensive Stage 1Salivary Gland Neoplasms 1Pathologic Complete Response 1Papillomavirus Infections 1Oropharyngeal Neoplasms 1Neoplasms 1Myelosuppression 1Myeloproliferative Disorders 1Mouth Neoplasms 1Melanoma 1Lymphoma, Non-Hodgkin 1Leukopenia 1Leiomyoma 1Hypersplenism 1Hemoglobinuria, Paroxysmal 1Hematologic Diseases 1Growth Hormone-Secreting Pituitary Adenoma 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Colorectal Liver Metastases 1

Interventions

toripalimab 6Cisplatin 5130-nm albumin-bound paclitaxel 5Drug Therapy 4tislelizumab 3sintilimab 3camrelizumab 3Injections 3Immune Checkpoint Inhibitors 3Fluorouracil 3Carboplatin 3nedaplatin 2anlotinib 2Radiotherapy 2Paclitaxel 2Neoadjuvant Therapy 2Irinotecan 2Esophagectomy 2potassium oxonate 1pembrolizumab 1lenvatinib 1ivarmacitinib 1irinotecan sucrosofate 1Watchful Waiting 1Taxes 1TP protocol 1S 1 (combination) 1Radiotherapy, Intensity-Modulated 1Radiation 1Observation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Esophageal Squamous Cell Carcinoma × Observation × Clear all
NCT07067450 2025-07-16

Adjuvant Immunotherapy for Esophageal Squamous Cell Carcinoma

Sichuan University

Phase NA Not yet recruiting
98 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡